As we dive right into 2023, medical affairs teams are at a turning point.
MSLs are no longer wasting valuable time waiting in line within the halls of ivory towers, trying to get face-time or…
Clinicians are using artificial intelligence (AI) to enhance clinical decision-making and improve patient outcomes when it comes to cerebral aneurysms. Aneurysms are difficult to monitor due to their…
Continue Reading
Technological advancements have been longstanding catalysts for change in healthcare. Clinical laboratories have undergone major changes as well with the introduction of new diagnostic techniques and tests born out of the research of fundamental…
Continue Reading
The market for mobile health devices is rapidly changing with the development of smartphones, wearable watches, patient monitoring devices, and even rings and wristbands that monitor patient vital signs like heart rate, body temperature,…
Continue Reading
The following is a guest article by Josh Wilda, CIO at University of Michigan Health-West.
Armando Ruiz is like many who walk through the doors of Exalta Health: an elderly man greeted in his native…
Continue Reading![Interoperability and Price Transparency in the 21st Century Cures Act: A Payer’s Perspective [Sponsored]](https://i0.wp.com/www.mediformatica.com/wp-content/uploads/2023/03/interoperability-and-price-transparency-in-the-21st-century-cures-act-a-payers-perspective-sponsored.jpg?fit=600%2C337&ssl=1)
Although it was signed into law in 2016, portions of the 21st Century Cures Act, the provisions designed to support interoperability continue created the need for new rules by the Centers for Medicare and…
Continue Reading
By Mark Melchionna March 06, 2023 – Amid a rapidly growing youth mental health crisis, Brightline and Evernorth Health Services have formed a partnership to support children and their families by expanding…
Continue Reading
Jayne Goes to ATA
I have arrived at the American Telemedicine Association meeting in San Antonio, escaping the freezing rain of the Midwest for the blindingly bright sun of Texas.
Since it’s been…
Chroma Medicine, a biotech company developing therapies that turn genes on or off as a way of treating genetic disorders, has raised $135 million as it works to generate data that could show the…
Continue Reading
Patients whose blood cancer advances after initial treatments have one last therapeutic option: the engineering of their immune cells into a living medicine. But cancer is crafty and it often finds a way to…
Continue Reading
